2021/8/7~8/8 

Welcome Address                                                     Distinguished Guest

001  2

Keynote Lecture(I) Unmet need of HBV management           Functional cure of hepatitis B

3   4

Basic studies of HBV                                                  New advance in HBV and HCV coinfection

5   6

Keynote Lecture(II) Toward global HCV elimination       Extrahepatic manifestation after HCV cure

7    8                     

Gap toward HCV elimination                               Unmet need of medical Treatment of HCV infection       

9    10  

Oral Presentation

11    12       

13   14

15   16                  

17   18

19

Closing Remarks & Welcome Address                         MAFLD:New Concept and Clinical Implications    

20   21

Advance in the pathology of metabolic fatty liver disease

22

Keynote Lecture(III)

Leveraging Energy Expenditure in the Management of Non-Alcoholic Fatty Liver Disease

23

Keynote Lecture(IV)

Impact of dietary fat on the steatosis-associated liver tumorigenesis

24

Update of systemic therapy for HCC

25

Emerging advance of immunotherapy-based strategy for HCC

26

Efficacy of target and immunotherapy among different etiologies of aHCC

27

Gut microbiota and NAFLD/NASH

28

Closing Remarks

29

Group photo of all staff

30